CompletedNot Applicable

Life Satisfaction and Psychopathology in Institutionalized Elderly People

12 participantsStarted 2015-06

Plain-language summary

The present study attempted to test the benefits of a Mindfulness-Based Stress Reduction (MBSR) program in Portuguese institutionalized elderly people, as a way to improve life satisfaction and reduce psychopathology. The sample included 12 institutionalized elderly people, with ages between 65 and 91 (M = 82.58 years; SD = 7.87), that filled several selfreport questionnaires and were assessed with Mini Mental State Examination. Participants attended to an adapted Mindfulness-Based Stress Reduction program (KabatZinn,1994), with 48 sessions (16 weeks) and Participants were evaluated before and after the intervention.

Who can participate

Age range

65 Years – 95 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * literacy * age above 65 years Exclusion Criteria: * presence of cognitive or sensorial * impairment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in depression levels assessed with the GDS

Timeframe: Pre-test and Post-test (4 months later)

Change in anxiety levels assessed with the DASS-21

Timeframe: Pre-test and Post-test (4 months later)

Change in experiential avoidance levels assessed with the AAQ-II

Timeframe: Pre-test and Post-test (4 months later)

Change in subjective pain levels assessed with the Faces Scale

Timeframe: Pre-test and Post-test (4 months later)

Change in life satisfaction levels assessed with the SWLS

Timeframe: Pre-test and Post-test (4 months later)

Trial details

NCT IDNCT02774018

SponsorIrmandade da Misericórdia de Albergaria-a-Velha

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-10

View on ClinicalTrials.gov More Anxiety Depression (Mild or Not Persistent) trials

Plain-language summary

Who can participate

Age range

65 Years – 95 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * literacy * age above 65 years Exclusion Criteria: * presence of cognitive or sensorial * impairment

What they're measuring

Change in depression levels assessed with the GDS

Timeframe: Pre-test and Post-test (4 months later)

Change in anxiety levels assessed with the DASS-21

Timeframe: Pre-test and Post-test (4 months later)

Change in experiential avoidance levels assessed with the AAQ-II

Timeframe: Pre-test and Post-test (4 months later)

Change in subjective pain levels assessed with the Faces Scale

Timeframe: Pre-test and Post-test (4 months later)

Change in life satisfaction levels assessed with the SWLS

Timeframe: Pre-test and Post-test (4 months later)